BRIDGEBIO PHARMA, INC.

Lobbying for BRIDGEBIO PHARMA, INC. · Biotech company

Filing 4th Quarter - Amendment

4th Quarter (Oct 1 - Dec 31) 2023 · California · House · Senate · $140,000.00 expenses · posted Jul 17, 2026

Bills named in this filing 5

Lobbying activity 1

Pharmacy

ORPHAN Cures Act H.R. 5539; S. 3131 Promising Pathways Act HR 4408; S. 1906 PAHPA H.R.469 PAHPA S.R. 2333 Innovation in Pediatric Drugs Act of 2023

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.